These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 37164772)

  • 61. State of melanoma: an historic overview of a field in transition.
    Gorantla VC; Kirkwood JM
    Hematol Oncol Clin North Am; 2014 Jun; 28(3):415-35. PubMed ID: 24880939
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Metastatic uveal melanoma managed with best supportive care.
    Rantala ES; Hernberg MM; Lundin M; Lundin J; Kivelä TT
    Acta Oncol; 2021 Jan; 60(1):135-139. PubMed ID: 32960119
    [No Abstract]   [Full Text] [Related]  

  • 63. [Considerations for an end-of-life ethic].
    Joly C
    Rev Med Interne; 2015 Jun; 36(6):369-71. PubMed ID: 25547955
    [No Abstract]   [Full Text] [Related]  

  • 64. [How do we get around the barriers to integrating palliative care in oncology?].
    Sahut d'Izarn M; Vinant P; Bouleuc C
    Bull Cancer; 2022 May; 109(5):579-587. PubMed ID: 35034784
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Palliative care in maternity units].
    de Mézerac I
    Soins Pediatr Pueric; 2019; 40(306):19-21. PubMed ID: 30661775
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Breast lesions of a metastatic melanoma on a radiotherapy territory: Treatment by vemurafenib and carcinologic surgery].
    Fernandez J; Montaudié H; Courdi A; Georgiou C; Camuzard O; Chignon-Sicard B
    Ann Chir Plast Esthet; 2016 Feb; 61(1):69-75. PubMed ID: 25446470
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Deaths in France: Characteristics, place of death, hospitalisations and use of palliative care during the year before death.
    Poulalhon C; Rotelli-Bihet L; Raso C; Aubry R; Fagot-Campagna A; Tuppin P
    Rev Epidemiol Sante Publique; 2018 Feb; 66(1):33-42. PubMed ID: 29203132
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Advanced Disease Situations with Organic Brain Changes].
    Hedbom S; Catschegn S
    Praxis (Bern 1994); 2020 Nov; 109(15):1195-1199. PubMed ID: 33234034
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Recognising immunotherapy-induced meningoencephalitis: a case during treatment for primary metastatic melanoma of the bladder neck.
    Grunhut J; Brown S; Lutzky J; Skoczylas L
    BMJ Case Rep; 2022 Jul; 15(7):. PubMed ID: 35858738
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Identification of a pyroptosis-based model for predicting clinical outcomes from immunotherapy in patients with metastatic melanoma.
    Wu G; Chen B; Jiang J; Chen Y; Chen Y; Wang H
    Cancer Med; 2023 Feb; 12(4):4921-4937. PubMed ID: 36151761
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Metastatic primary gastric melanoma: a rare clinical presentation and a review of literature.
    Mahapatra BR; Muraleedharan A; Das Majumdar SK; Adhya AK
    BMJ Case Rep; 2022 Jul; 15(7):. PubMed ID: 35835487
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [ANOCEF guidelines for the management of brain metastases].
    Le Rhun É; Dhermain F; Noël G; Reyns N; Carpentier A; Mandonnet E; Taillibert S; Metellus P;
    Cancer Radiother; 2015 Feb; 19(1):66-71. PubMed ID: 25666314
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Analysis of HLA class I expression in progressing and regressing metastatic melanoma lesions after immunotherapy.
    Carretero R; Romero JM; Ruiz-Cabello F; Maleno I; Rodriguez F; Camacho FM; Real LM; Garrido F; Cabrera T
    Immunogenetics; 2008 Aug; 60(8):439-47. PubMed ID: 18545995
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Surveillance of the eye and vision in clinical trials of CP-675,206 for metastatic melanoma.
    Straatsma BR; Nusinowitz S; Young TA; Gordon LK; Chun MW; Rosen C; Seja E; Economou JS; Glaspy JA; Bozon V; Gomez-Navarro J; Ribas A
    Am J Ophthalmol; 2007 Jun; 143(6):958-969. PubMed ID: 17434437
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Rapidly progressing metastatic malignant melanoma mimicking primary pleural tumor: A case report.
    So C; Yoshida T; Mizuno T; Yatabe Y; Ohe Y
    Thorac Cancer; 2022 May; 13(9):1423-1426. PubMed ID: 35315237
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Evidence-based and interdisciplinary consensus-based German guidelines: systemic medical treatment of melanoma in the adjuvant and palliative setting.
    Garbe C; Hauschild A; Volkenandt M; Schadendorf D; Stolz W; Reinhold U; Kortmann RD; Kettelhack C; Frerich B; Keilholz U; Dummer R; Sebastian G; Tilgen W; Schuler G; Mackensen A; Kaufmann R
    Melanoma Res; 2008 Apr; 18(2):152-60. PubMed ID: 18337653
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Long-term remission of malignant melanoma stage IV after antigen-specific immunotherapy].
    Neumann A; Karbach J; Atmaca A; Jäger E
    Med Klin (Munich); 2010 Apr; 105(4):273-5. PubMed ID: 20455048
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Not Available].
    Mateus C; Libenciuc C; Robert C
    Bull Cancer; 2016 Jun; 103(6 Suppl 1):S4-S11. PubMed ID: 27494973
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The Option Value of Innovative Treatments for Metastatic Melanoma.
    Thornton Snider J; Seabury S; Tebeka MG; Wu Y; Batt K
    Forum Health Econ Policy; 2018 Jun; 21(1):. PubMed ID: 30210050
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Tumor-infiltrating lymphocyte therapy in metastatic melanoma.
    Chesney JA
    Clin Adv Hematol Oncol; 2023 Jan; 21(1):49-51. PubMed ID: 36638357
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.